Addiction Science & Clinical Practice is affiliated with the International Network on Brief Interventions for Alcohol & Other Drugs.
Articles
Page 1 of 18
-
Citation: Addiction Science & Clinical Practice 2024 19:69
-
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Incarceration provides an opportunity for health interventions, including opioid use disorder (OUD) treatment and prevention of opioid-related overdoses post-release. All FDA-approved forms of medication for O...
Citation: Addiction Science & Clinical Practice 2024 19:68 -
Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital
Adolescents with chronic medical conditions (CMC) use alcohol and marijuana at levels equal to or even greater than their peers without CMC and are more likely to initiate substance use at 14 years or younger....
Citation: Addiction Science & Clinical Practice 2024 19:67 -
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial
Patients with chronic pain on opioids frequently experience loneliness, which is associated with poorer health outcomes and higher risk for opioid misuse and opioid use disorder. Given that almost half of opio...
Citation: Addiction Science & Clinical Practice 2024 19:66 -
Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals
Hazardous alcohol use and alcohol use disorder (AUD) are highly prevalent among clients in mental health services, yet significant gaps remain in the adequate assessment of alcohol use and provision of appropr...
Citation: Addiction Science & Clinical Practice 2024 19:65 -
Integrated telehealth intervention to reduce chronic pain and unhealthy drinking among people living with HIV: protocol for a randomized controlled trial
Unhealthy alcohol use represents a significant risk for morbidity and mortality among people living with HIV (PLWH), in part through its impact on HIV management. Chronic pain, a common comorbidity, exacerbate...
Citation: Addiction Science & Clinical Practice 2024 19:64 -
Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol
Opioid related overdose morbidity and mortality continue to significantly impact rural communities. Nationwide, emergency departments (EDs) have seen an increase in opioid use disorder (OUD)-related visits com...
Citation: Addiction Science & Clinical Practice 2024 19:63 -
Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study
Unhealthy alcohol use is a common public health problem in HIV care settings in Africa and it affects the HIV continuum of care. In Uganda and other low-income countries, HIV care providers are a key resource ...
Citation: Addiction Science & Clinical Practice 2024 19:62 -
Prevalence of alcohol use disorders documented in electronic health records in primary care across intersections of race or ethnicity, sex, and socioeconomic status
Diagnosis of alcohol use disorder (AUD) in primary care is critical for increasing access to alcohol treatment. However, AUD is underdiagnosed and may be inequitably diagnosed due to societal structures that d...
Citation: Addiction Science & Clinical Practice 2024 19:61 -
Ketamine-assisted buprenorphine initiation: a pilot case series
Many people with opioid use disorder who stand to benefit from buprenorphine treatment are unwilling to initiate it due to experience with or fear of both spontaneous and buprenorphine-precipitated opioid with...
Citation: Addiction Science & Clinical Practice 2024 19:60 -
Introduction to the special series: using evidence to enhance health services for individuals using drugs in rural communities
Citation: Addiction Science & Clinical Practice 2024 19:59 -
“Moving beyond silos”: focus groups to understand the impact of an adapted project ECHO model for a multidisciplinary statewide forum of substance use disorder care leaders
Although clinical substance use disorder (SUD) care is multidisciplinary there are few opportunities to collaborate for quality improvement or systems change. In Oregon, the Project ECHO (Extension for Communi...
Citation: Addiction Science & Clinical Practice 2024 19:58 -
Exploring perceptions of genetic risk and the transmission of substance use disorders
Substance use disorders (SUDs) have been consistently shown to exhibit moderate intergenerational continuity (1–3). While much research has examined genetic and social influences on addiction, less attention h...
Citation: Addiction Science & Clinical Practice 2024 19:57 -
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder
Despite continuing advancements in treatments for opioid use disorder (OUD), continued high rates of relapse indicate the need for more effective approaches, including novel pharmacological interventions. Gluc...
Citation: Addiction Science & Clinical Practice 2024 19:56 -
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial
In the U.S. there are significant racial and gender disparities in the uptake of pre-exposure prophylaxis (PrEP). Black Americans represented 14% of PrEP users in 2022, but accounted for 42% of new HIV diagnos...
Citation: Addiction Science & Clinical Practice 2024 19:55 -
A case of severe opioid and methamphetamine use disorder in a 14 year old
We present the case of a 14-year-old who established care at our primary care clinic after hospitalization for unintentional fentanyl overdose. They were diagnosed with severe opioid use disorder (OUD) and sti...
Citation: Addiction Science & Clinical Practice 2024 19:54 -
Patient experiences of buprenorphine dispensing from a mobile medical unit
Overdose deaths continue to rise within the United States, despite effective treatments such as buprenorphine and methadone for opioid use disorder (OUD). Mobile medical units with the ability to dispense bupr...
Citation: Addiction Science & Clinical Practice 2024 19:53 -
Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial
Cigarette smoking remains a leading cause of preventable illness and death, underscoring the need for effective evidence-based smoking cessation interventions. Nuumi, a novel smoking cessation program integrat...
Citation: Addiction Science & Clinical Practice 2024 19:52 -
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders
Clinic-based interventions are needed to promote successful direct acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection in patients with substance use disorders (SUDs) among rural Vet...
Citation: Addiction Science & Clinical Practice 2024 19:51 -
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine is an effective and safe treatment for opioid use disorder, but the requirement for moderate opioid withdrawal symptoms to emerge prior to initiation is a significant treatment barrier.
Citation: Addiction Science & Clinical Practice 2024 19:50 -
The identification and treatment of alcohol problems in primary care (iTAPP) study: protocol for a stepped wedge cluster randomized control trial testing the 15-method in a primary care setting
The 15-method is a targeted screening and treatment approach for alcohol problems in primary care. The 15-method used in primary care has proven as effective as specialized treatment for mild to moderate alcoh...
Citation: Addiction Science & Clinical Practice 2024 19:49 -
Using 42 CFR part 2 revisions to integrate substance use disorder treatment information into electronic health records at a safety net health system
Regulations put in place to protect the privacy of individuals receiving substance use disorder (SUD) treatment have resulted in an unintended consequence of siloed SUD treatment and referral information outsi...
Citation: Addiction Science & Clinical Practice 2024 19:48 -
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs
Women who engage in sex work and use drugs (WSWUD) experience disproportionate HIV risks. Substance use treatment bridge clinics offer an opportunity to increase HIV pre-exposure prophylaxis (PrEP) delivery to...
Citation: Addiction Science & Clinical Practice 2024 19:47 -
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods
Implementation of pre-exposure prophylaxis (PrEP) to prevent HIV transmission is suboptimal in the United States, particularly among people who use drugs (PWUD). PrEP research among PWUD is scarce, and the fac...
Citation: Addiction Science & Clinical Practice 2024 19:46 -
Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities
Supervised injectable opioid treatment (SIOT) is a promising alternative for people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral opioid substitution treatment. Yet, SIOT...
Citation: Addiction Science & Clinical Practice 2024 19:45 -
Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges
Norway has a growing proportion of ageing opioid agonist treatment (OAT) patients, with 42% of the 8300 Norwegian OAT patients aged over 50 in 2022. This study aims to explore practitioners’ views and experien...
Citation: Addiction Science & Clinical Practice 2024 19:44 -
Confidence in providing methadone maintenance treatment of primary care providers in Vietnam
Delivering methadone treatment in community health facilities by primary care providers is a task-shifting strategy to expand access to drug use treatment, especially in rural mountainous areas. This study aim...
Citation: Addiction Science & Clinical Practice 2024 19:43 -
A social network analysis approach to assess COVID19-related disruption to substance use treatment and informal social interactions among people who use drugs in Scotland
To assess the extent of Coronavirus-related disruption to health and social care treatment and social interactions among people with lived or living experience of substance use in Scotland, and explore potenti...
Citation: Addiction Science & Clinical Practice 2024 19:42 -
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Alcohol-attributable medical disorders are prevalent among individuals with alcohol use disorder (AUD). However, there is a lack of research on prescriptions of pharmacological treatment for AUD in those with ...
Citation: Addiction Science & Clinical Practice 2024 19:41 -
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol
People with substance use disorders (SUDs) have restricted engagement with health-care facilities and describe repeated experiences of stigma, discrimination, and mistreatment when receiving care at health-car...
Citation: Addiction Science & Clinical Practice 2024 19:40 -
Retention of people who inject drugs enrolled in a ‘medications for opioid use disorder’ (MOUD) programme in Uganda
Injection Drug use is associated with increased HIV risk behaviour that may result in the transmission of HIV and poor access to HIV prevention and treatment. In 2020, Uganda introduced the ‘medication for opi...
Citation: Addiction Science & Clinical Practice 2024 19:39 -
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda
Children at risk of substance use disorders (SUD) should be detected using brief structured tools for early intervention. This study sought to translate and adapt the Car, Relax, Alone, Forget, Family/Friends,...
Citation: Addiction Science & Clinical Practice 2024 19:38 -
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
Knowledge of co-occurring mental disorders (termed ‘dual diagnosis’) among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual dia...
Citation: Addiction Science & Clinical Practice 2024 19:37 -
Boosting self-efficacy and improving practices for smoking prevention and cessation among South American cancer care providers with a web-based algorithm
Digital technologies have positively impacted the availability and usability of clinical algorithms through the advancement in mobile health. Therefore, this study aimed to determine if a web-based algorithm d...
Citation: Addiction Science & Clinical Practice 2024 19:36 -
Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for individuals with alcohol use disorder
As the return to alcohol use in individuals with alcohol use disorder (AUD) is common during treatment and recovery, it is important that abstinence motivation is maintained after such critical incidences. Our...
Citation: Addiction Science & Clinical Practice 2024 19:35 -
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report
Zoledronate, a bisphosphonate, is a potent first-line treatment for osteoporosis. It is also a preferred treatment for hypercalcemia especially when unresponsive to intravenous fluids. Bisphosphonates can caus...
Citation: Addiction Science & Clinical Practice 2024 19:34 -
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial
Individuals with substance use disorders (SUDs) frequently use acute hospital services. The Navigation Services to Avoid Rehospitalization (NavSTAR) trial found that a patient navigation intervention for hospi...
Citation: Addiction Science & Clinical Practice 2024 19:33 -
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare
Health care providers are a key source of reports of infants to child welfare related to birthing people’s substance use. Many of these reports are overreports, or reports that exceed what is legally mandated,...
Citation: Addiction Science & Clinical Practice 2024 19:32 -
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder
Hospitalization presents an opportunity to begin people with opioid use disorder (OUD) on medications for opioid use disorder (MOUD) and link them to care after discharge; regrettably, people admitted to the h...
Citation: Addiction Science & Clinical Practice 2024 19:31 -
Internet-delivered therapy for alcohol misuse: engagement, satisfaction, and outcomes when patients select their preference for therapist- or self-guided treatment
Alcohol misuse is common and causes substantial harm. Internet-delivered cognitive behaviour therapy (ICBT) is effective in reducing alcohol misuse; however, the literature investigating how treatment outcomes...
Citation: Addiction Science & Clinical Practice 2024 19:30 -
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder
Hospitalizations involving opioid use disorder (OUD) are increasing. Medications for opioid use disorder (MOUD) reduce mortality and acute care utilization. Hospitalization is a reachable moment for initiating...
Citation: Addiction Science & Clinical Practice 2024 19:29 -
The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial
Substance use disorder (SUD) is associated with executive function (EF) deficits and sensory modulation dysfunction (SMD). Yet, these deficits are not addressed therapeutically. This study aims to examine the ...
Citation: Addiction Science & Clinical Practice 2024 19:28 -
Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies
Pharmacy-based screening and brief interventions (SBI) offer opportunities to identify opioid misuse and opioid safety risks and provide brief interventions that do not overly burden pharmacists. Currently, su...
Citation: Addiction Science & Clinical Practice 2024 19:27 -
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process
Emergency departments (ED) are incorporating Peer Support Specialists (PSSs) to help with patient care for substance use disorders (SUDs). Despite rapid growth in this area, little is published regarding workf...
Citation: Addiction Science & Clinical Practice 2024 19:26 -
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study
Long-acting injectable buprenorphine (LAIB) formulations are a novel treatment approach in opioid agonist treatment (OAT), which provide patients with a steady dose administered weekly or monthly and thus redu...
Citation: Addiction Science & Clinical Practice 2024 19:25 -
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use
The Cannabis Abuse Screening Test (CAST) is a widely used screening tool for identifying patterns of cannabis use that have negative health or social consequences for both the user and others involved. This br...
Citation: Addiction Science & Clinical Practice 2024 19:24 -
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
Communities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based ...
Citation: Addiction Science & Clinical Practice 2024 19:23 -
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
Hospitalization is a “reachable moment” for people who inject drugs (PWID), but preventive care including HIV testing, prevention and treatment is rarely offered within inpatient settings.
Citation: Addiction Science & Clinical Practice 2024 19:22 -
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
People who inject drugs (PWID) remain a high priority population under the federal Ending the HIV Epidemic initiative with 11% of new HIV infections attributable to injection drug use. There is a critical need...
Citation: Addiction Science & Clinical Practice 2024 19:21 -
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment
Amidst increasing opioid-related fatalities in adolescents and young adults (AYA), there is an urgent need to enhance the quality and availability of developmentally appropriate, evidence-based treatments for ...
Citation: Addiction Science & Clinical Practice 2024 19:20
Follow
Affiliated with
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.7
5-year Journal Impact Factor: 4.2
Source Normalized Impact per Paper (SNIP): 1.062
SCImago Journal Rank (SJR): 1.307
Speed 2023
Submission to first editorial decision (median days): 28
Submission to acceptance (median days): 202
Usage 2023
Downloads: 755,413
Altmetric mentions: 622
Archival content
Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.